A detailed history of Brinker Capital Investments, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 8,736 shares of DGX stock, worth $1.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,736
Previous 9,108 4.08%
Holding current value
$1.2 Million
Previous $1.12 Million 22.29%
% of portfolio
0.03%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$123.31 - $157.26 $45,871 - $58,500
-372 Reduced 4.08%
8,736 $1.37 Million
Q3 2022

Nov 01, 2022

SELL
$121.77 - $141.1 $10,350 - $11,993
-85 Reduced 0.92%
9,108 $1.12 Million
Q2 2022

Jul 18, 2022

SELL
$127.07 - $145.39 $2.29 Million - $2.63 Million
-18,058 Reduced 66.27%
9,193 $1.22 Million
Q1 2022

May 16, 2022

BUY
$129.09 - $164.35 $2.23 Million - $2.84 Million
17,300 Added 173.85%
27,251 $3.73 Million
Q4 2021

Feb 08, 2022

SELL
$140.36 - $173.01 $80,145 - $98,788
-571 Reduced 5.43%
9,951 $1.72 Million
Q2 2021

Aug 03, 2021

SELL
$126.66 - $141.48 $402,398 - $449,481
-3,177 Reduced 23.19%
10,522 $1.39 Million
Q1 2021

May 12, 2021

SELL
$114.63 - $133.34 $793,812 - $923,379
-6,925 Reduced 33.58%
13,699 $1.76 Million
Q4 2020

Feb 16, 2021

BUY
$112.7 - $128.05 $663,126 - $753,446
5,884 Added 39.92%
20,624 $2.46 Million
Q3 2020

Dec 03, 2020

BUY
$107.05 - $130.01 $1.58 Million - $1.92 Million
14,740 New
14,740 $1.69 Million
Q3 2019

Nov 14, 2019

SELL
$97.85 - $107.42 $5,968 - $6,552
-61 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$80.68 - $89.92 $4,921 - $5,485
61 New
61 $5,000
Q4 2017

Feb 12, 2018

SELL
$90.86 - $100.24 $3,180 - $3,508
-35 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$91.96 - $108.35 $3,218 - $3,792
35
35 $3,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.